Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide in Refractory Partial Seizures
NCT00327717Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zonisamide in focal seizures, sponsored by Eisai Co., Ltd.. Started Sep 2006; status: completed.
02
Drugs
zonisamide
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00327717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327717.